関連する実験動画
Updated: Jul 13, 2026

23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
臨床医が開発に関する知識にどのように貢献するか.
1University of Manchester, Academic Unit of Medical Genetics and Regional Genetic Service, St Mary's Hospital, M13 0JH, Manchester, UK. dian.donnai@cmmc.nhs.uk
Lancet (London, England)
|August 21, 2003
まとめ
人間の生まれつきの欠陥の研究は,単親分裂のような重要な発達遺伝子やメカニズムを明らかにしています. これらの発見は,しばしばヒトの研究に特有のもので,発達生物学に関する私たちの理解を深めています.
科学分野:
- 発達生物学 発達生物学とは
- ヒューマン・ジェネティクス ヒューマン・ジェネティックス
- クリニック・リサーチ 臨床研究
背景:
- 人間の生まれつきの欠陥や発達障害は,根本的な発達プロセスに関するユニークな洞察を提供します.
- 希少なヒト症候群は,重要な発達遺伝子を特定する上で重要な役割を果たしてきました.
- ユニパレンタルディソミーや不安定なトリヌクレオチドの繰り返しなどのメカニズムは,ヒトの研究を通じて発見されました.
研究 の 目的:
- 発達生物学に対するヒト研究の重要な貢献を強調する.
- 人間の臨床観察と動物モデル研究との相互作用を強調する.
- 認知発達を含む人間の発達特有の側面を研究することの重要性を強調する.
主な方法:
- 人間の生まれつきの欠陥や発達障害の症例の分析.
- 希少なヒト症候群に関連した遺伝子の特定.
- 動物モデルの研究の結果と比較分析.
主要な成果:
- 希少なヒト症候群の研究を通じて,新しい発達遺伝子の発見.
- 動物モデルでこれまで観察されていないユニークな発達メカニズムを特定する.
- 種間の保存された発達メカニズムの実証,学際的な洞察を促進します.
結論:
- 人間の研究は,特に人間に特有の側面について,開発を理解するために不可欠です.
- 希少なヒト症候群は,遺伝子発見と機械的洞察のための貴重なデータを提供します.
- 発達生物学を進歩させるために,ヒトの臨床研究と動物研究の間に,シナジスティックな関係が存在します.
関連する概念動画
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data from the...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data from the...
Health Literacy
Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative programs,...
Patient-centered Care
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
Critical Thinking I
Critical thinking helps decision-making and allows nurses to recognize barriers to success and find solutions to possible issues. It helps to brainstorm and implement ideas to achieve goals. Critical thinking helps acknowledge and state workflow inefficiencies while improving management techniques. Nurses understand the value of critical thinking and look for fellow nurses with critical thinking skills to upgrade their professional standards. Critical thinking can advance a nurse's career with...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

